26
Sep

Gilead Sciences, already a trailblazer in hepatitis C treatment, is creeping up on its next milestone: approval for a combination therapy that promises to cure the majority of patients without the need for painful injections.

…read more

Source: Gilead nears EU approval for the next big thing in hep C

    

0 No comments